Stockscreener 앱 받기
115.18
1.66%
-1.94
시간 외 거래:
115.18
전일 마감가:
$117.12
열려 있는:
$116.47
하루 거래량:
1.02M
Relative Volume:
0.59
시가총액:
$8.80B
수익:
$8.10B
순이익/손실:
$599.48M
주가수익비율:
15.57
EPS:
7.3969
순현금흐름:
$971.25M
1주 성능:
+1.88%
1개월 성능:
+15.53%
6개월 성능:
-40.40%
1년 성능:
-16.07%
1일 변동 폭
$114.10
$118.68
1주일 범위
$112.53
$121.03
52주 변동 폭
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Compare ICLR vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
115.18 | 8.94B | 8.10B | 599.48M | 971.25M | 7.3969 |
TMO
Thermo Fisher Scientific Inc
|
524.57 | 195.48B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.54 | 138.36B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.01 | 46.31B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.09 | 34.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
335.23 | 32.95B | 3.17B | 642.63M | 516.49M | 10.77 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-26 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2026-02-23 | 업그레이드 | Jefferies | Hold → Buy |
| 2026-02-18 | 업그레이드 | TD Cowen | Hold → Buy |
| 2026-02-17 | 다운그레이드 | Rothschild & Co Redburn | Buy → Neutral |
| 2026-02-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2026-02-12 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2026-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-09-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-09-03 | 업그레이드 | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-07-24 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-04-14 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-04-10 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-03-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-01-07 | 개시 | RBC Capital Mkts | Outperform |
| 2024-10-24 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | 개시 | Redburn Atlantic | Neutral |
| 2024-09-18 | 개시 | Leerink Partners | Outperform |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2023-12-15 | 개시 | Truist | Buy |
| 2023-09-13 | 개시 | TD Cowen | Outperform |
| 2023-01-17 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-01-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-11-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-09-07 | 개시 | UBS | Buy |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-05-24 | 개시 | Guggenheim | Buy |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-09-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-23 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-14 | 개시 | Citigroup | Neutral |
| 2021-04-13 | 재개 | BofA Securities | Neutral |
| 2021-04-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | 개시 | Barclays | Equal Weight |
| 2021-03-01 | 업그레이드 | UBS | Neutral → Buy |
| 2021-02-26 | 업그레이드 | Truist | Hold → Buy |
| 2020-07-24 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-04-20 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-03-02 | 개시 | Deutsche Bank | Hold |
| 2020-01-27 | 다운그레이드 | SunTrust | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-09-23 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | 업그레이드 | UBS | Sell → Neutral |
| 2019-01-25 | 업그레이드 | Mizuho | Neutral → Buy |
| 2018-10-26 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-10-09 | 개시 | UBS | Sell |
| 2018-04-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2018-02-15 | 재확인 | Mizuho | Neutral |
| 2018-01-19 | 개시 | Evercore ISI | Outperform |
| 2017-10-27 | 재확인 | Barclays | Equal Weight |
| 2017-09-11 | 개시 | BofA/Merrill | Buy |
| 2017-07-31 | 업그레이드 | SunTrust | Hold → Buy |
| 2017-07-27 | 재확인 | Mizuho | Neutral |
| 2017-06-29 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Icon Plc 주식(ICLR)의 최신 뉴스
Icon Plc (NASDAQ:ICLR) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
ICON plc options imply 11.5% move in share price post-earnings - TipRanks
Hudson Edge Investment Partners Inc. Has $47.46 Million Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Analysis: Potential Upside with Strategic Global Reach Captivates Investors - DirectorsTalk Interviews
Icon PLC (MEX:ICLRN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
MEX:ICLRN EV-to-EBIT: 13.38 — 37% Below Median - GuruFocus
Icon PLC (MEX:ICLRN) Stock Price & 30 Year Financial Data - GuruFocus
Icon Plc $ICLR Shares Sold by Ninety One UK Ltd - MarketBeat
Ninety One North America Inc. Purchases 12,552 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Acquired by Fisher Funds Management LTD - MarketBeat
ICON plc options imply 9.7% move in share price post-earnings - TipRanks
Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Maintains Target Price $120 - 富途牛牛
ICON plc stock (IE0005711209): Why its clinical trial dominance matters more now for U.S. investors? - AD HOC NEWS
ICON Launches New Functional Service Provision (FSP) Strategy - AOL.com
USS Investment Management Ltd's Icon PLC(ICLR) Holding History - GuruFocus
Is It Too Late to Buy Icon PLC (ICLR) After 3.0% Rally? GF Value Says Undervalued - GuruFocus
Icon Plc (NASDAQ:ICLR) Short Interest Update - MarketBeat
Timber Creek Capital Management LLC Makes New $5.65 Million Investment in Icon Plc $ICLR - MarketBeat
Is ICON (NasdaqGS:ICLR) Offering An Opportunity After Recent Share Price Volatility? - Sahm
ICON plc stock (IE0005711209): Is clinical trial demand strong enough to drive U.S. investor upside? - AD HOC NEWS
Massachusetts Financial Services Co. MA Has $429.50 Million Holdings in Icon Plc $ICLR - MarketBeat
ALTRINSIC GLOBAL ADVISORS LLC's Icon PLC(ICLR) Holding History - GuruFocus
Analysts Offer Insights on Healthcare Companies: Icon (ICLR) and Neogen (NEOG) - The Globe and Mail
Mizuho Securities Maintains Icon PLC(ICLR.US) With Buy Rating, Cuts Target Price to $180 - 富途牛牛
Trinity Street Asset Management LLP Increases Stock Position in Icon Plc $ICLR - MarketBeat
ICON plc (ICLR) Stock Forecasts - Yahoo! Finance Canada
ICON Public Limited Company (ICLR) stock price, news, quote and history - Yahoo Finance UK
Icon Plc $ICLR Shares Acquired by Aberdeen Group plc - MarketBeat
Downgrading Icon's Moat Rating to None; Yet Shares Appear Undervalued Amid Significant Pullback - Morningstar
Icon: Downgrading Moat Rating to None; Yet Shares Appear Undervalued Amid Significant Pullback - Morningstar
How ICON’s AI-Focused Partnership with Advarra Could Reshape ICLR’s Clinical Trial Efficiency Narrative - simplywall.st
Healthcare Rpo Market Is Going to Boom | • ICON plc • Syneos Health • Labcorp - openPR.com
ICLR Technical Analysis & Stock Price Forecast - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Fund Update: 1,985,017 ICON PLC (ICLR) Shares Added to GREENHAVEN ASSOCIATES INC Portfolio - Moomoo
Fund Update: 1,985,017 ICON PLC (ICLR) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative
Walter Public Investments Inc.'s Icon PLC(ICLR) Holding History - GuruFocus
A Look At ICON (ICLR) Valuation After Q1 Earnings Miss And Recent Share Price Volatility - simplywall.st
ICON PLC earnings missed by $0.02, revenue was in line with estimates - Investing.com South Africa
Icon (ICLR) Dividend-Payout-to-FFO - GuruFocus
ICLR 3-Year EBITDA Growth Rate: 28.40% — 176% Above Median - GuruFocus
MEX:ICLR EV-to-OCF: 9.32 — 56% Below Median - GuruFocus
Beyond the Lab: Biomarkers Powering Tomorrow’s Therapies - Drug Target Review
Icon PLC Forges Strategic Alliance Amidst Financial Review - AD HOC NEWS
Icon Plc $ICLR Shares Bought by Allspring Global Investments Holdings LLC - MarketBeat
Icon PLC (ICLR) Stock Price Up 3.93% on Mar 30 - GuruFocus
Precision Trading with Icon Plc (ICLR) Risk Zones - Stock Traders Daily
ICON Stock Trades At Deep Discount Amid Probe - Let's Data Science
Is ICON Public Limited Company (ICLR) A Good Stock To Buy Now? - Insider Monkey
Why ICON (ICLR) Is Up 5.1% After New AI-Powered Clinical Trial Partnership With Advarra - simplywall.st
Icon Plc (ICLR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.57%
0.03%
자본화:
|
볼륨(24시간):